Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Asendorf

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Rheumatology|March 3, 2022
Whole-body cryotherapy for the treatment of rheumatoid arthritis: a monocentric, single-blinded, randomised controlled trialPhilipp Klemm, Jutta Hoffmann, Thomas Asendorf, et al.
Clinical Oral Investigations|August 10, 2023
The impact of orthodontic-surgical treatment on facial expressions-a four-dimensional clinical trialAnja Quast, Monika Sadlonova, Thomas Asendorf, et al.
Journal of Affective Disorders|November 17, 2019
Measurement invariance of assessments of depression (PHQ-9) and anxiety (GAD-7) across sex, strata and linguistic backgrounds in a European-wide sample of patients after Traumatic Brain InjuryAli Teymoori, Ruben Real, Anastasia Gorbunova, et al.
Abdominal Radiology (New York)|April 23, 2018
Parametric response mapping cut-off values that predict survival of hepatocellular carcinoma patients after TACEAventinus Nörthen, Thomas Asendorf, Hoen-Oh Shin, et al.
Multiple Sclerosis and Related Disorders|October 15, 2023
Association of health behaviour and clinical manifestation in early multiple sclerosis in Germany - Baseline characteristics of the POWER@MS1 randomised controlled trialNicole Krause, Carlotta Derad, Barbara von Glasenapp, et al.
Clinical Chemistry|October 1, 2020
Time-Dependent Apparent Increase in dd-cfDNA Percentage in Clinically Stable Patients Between One and Five Years Following Kidney TransplantationEkkehard Schütz, Thomas Asendorf, Julia Beck, et al.
Frontiers in Oncology|February 13, 2023
Screening versus multidimensional assessment of symptoms and psychosocial distress in cancer patients from the time of incurabilityStefanie Solar, Johannes Wieditz, Florian Lordick, et al.
Biomedicines|October 23, 2021
Transcranial versus Direct Cortical Stimulation for Motor-Evoked Potentials during Resection of Supratentorial Tumors under General Anesthesia (The TRANSEKT-Trial): Study Protocol for a Randomized Controlled TrialTammam Abboud, Thomas Asendorf, Jutta Heinrich, et al.
Trials|March 19, 2026
Mixed-methods process evaluation of the "Karl-Heinz" cardiac prehabilitation program in older patients: protocol for the PRECOVERY trialAnnemieke Munderloh, Carolin Steinmetz, Stephanie Heinemann, et al.
Journal of Clinical Medicine|July 9, 2020
Reference Values of the QOLIBRI from General Population Samples in the United Kingdom and The NetherlandsAnastasia Gorbunova, Marina Zeldovich, Daphne C Voormolen, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Rheumatology|March 3, 2022
Whole-body cryotherapy for the treatment of rheumatoid arthritis: a monocentric, single-blinded, randomised controlled trialPhilipp Klemm, Jutta Hoffmann, Thomas Asendorf, et al.
Clinical Oral Investigations|August 10, 2023
The impact of orthodontic-surgical treatment on facial expressions-a four-dimensional clinical trialAnja Quast, Monika Sadlonova, Thomas Asendorf, et al.
Journal of Affective Disorders|November 17, 2019
Measurement invariance of assessments of depression (PHQ-9) and anxiety (GAD-7) across sex, strata and linguistic backgrounds in a European-wide sample of patients after Traumatic Brain InjuryAli Teymoori, Ruben Real, Anastasia Gorbunova, et al.
Abdominal Radiology (New York)|April 23, 2018
Parametric response mapping cut-off values that predict survival of hepatocellular carcinoma patients after TACEAventinus Nörthen, Thomas Asendorf, Hoen-Oh Shin, et al.
Multiple Sclerosis and Related Disorders|October 15, 2023
Association of health behaviour and clinical manifestation in early multiple sclerosis in Germany - Baseline characteristics of the POWER@MS1 randomised controlled trialNicole Krause, Carlotta Derad, Barbara von Glasenapp, et al.
Clinical Chemistry|October 1, 2020
Time-Dependent Apparent Increase in dd-cfDNA Percentage in Clinically Stable Patients Between One and Five Years Following Kidney TransplantationEkkehard Schütz, Thomas Asendorf, Julia Beck, et al.
Frontiers in Oncology|February 13, 2023
Screening versus multidimensional assessment of symptoms and psychosocial distress in cancer patients from the time of incurabilityStefanie Solar, Johannes Wieditz, Florian Lordick, et al.
Biomedicines|October 23, 2021
Transcranial versus Direct Cortical Stimulation for Motor-Evoked Potentials during Resection of Supratentorial Tumors under General Anesthesia (The TRANSEKT-Trial): Study Protocol for a Randomized Controlled TrialTammam Abboud, Thomas Asendorf, Jutta Heinrich, et al.
Trials|March 19, 2026
Mixed-methods process evaluation of the "Karl-Heinz" cardiac prehabilitation program in older patients: protocol for the PRECOVERY trialAnnemieke Munderloh, Carolin Steinmetz, Stephanie Heinemann, et al.
Journal of Clinical Medicine|July 9, 2020
Reference Values of the QOLIBRI from General Population Samples in the United Kingdom and The NetherlandsAnastasia Gorbunova, Marina Zeldovich, Daphne C Voormolen, et al.
Pageof 7